Patents Assigned to H. Lundebck A/S
  • Arylpyrrolopyridine Derived Compounds as LRRK2 Inhibitors
    Publication number: 20170020850
    Abstract: The present invention is directed to arylpyrrolopyridine derivatives of Formula A: The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease or cancer.
    Type: Application
    Filed: October 7, 2016
    Publication date: January 26, 2017
    Applicants: H. Lundebck A/S, Vernalis (R&D) Ltd.
    Inventors: Simon Timothy Bedford, I-Jen Chen, Yikang Wang, Douglas Stewart Williamson